Giacomo is currently Head of Global Rare Diseases at the Chiesi Group, where he leads the team developing and commercializing treatments for rare and ultra-rare diseases. His mission in life is to make a tangible difference in the lives of patients and alleviate all those who suffer from disease around the world. His passion is listening to patients and building and shaping organizations and put the feedback from the patients in practice. He was previously Head of Global Corporate Development at the Chiesi Group where he led the team through an intense deal making activity. The deals were instrumental for Chiesi to become a global company with expansion to several new countries including Canada, Australia and China, enter and grow its presence in the US market, selectively expand in new markets in Europe and establish a global portfolio and pipeline in rare diseases, which culminated in the constitution of a new organization: Chiesi Global Rare Diseases. In his career, Giacomo has directly structured and executed deals with $4B in value ranging from sell-side to buy-side M&A, in- and out-licensing, and spin-offs. In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital, an established life science venture capital fund, where he currently serves as Managing Partner. He serves as a Board Member on the Board of the Chiesi Group. He was previously¬ an observer or board member at Chiesi USA, Glycomine, Aura Biosciences, Sentien Biotech and Minoryx Therapeutics. Before joining the family business, Giacomo was a consultant with Bain & Company, a management consulting firm, where he led teams in a variety of assignments including due diligence, restructuring and strategy projects for consumer goods and IT companies in different countries. Previously he was with Accenture where he led large teams in outsourcing projects across Europe and US for clients in the transportation and retail businesses. Giacomo earned a Master of Science degree Magna cum Laude in Telecommunications Engineering from the University of Parma, Italy, and an MBA from the University of Chicago Booth School of Business with concentrations in Entrepreneurship, Economics and Finance. He practices calisthenics every day and enjoys spending time with his wife and kids, reading, traveling, and playing guitar. In 2021, he was awarded the Champion of Hope award from Global Genes and in 2022 he was a PharmaVoice 100 Honoree.